Novartis ‘abused’ discovery process for Zolgensma patent

23-05-2023

Sarah Speight

Novartis ‘abused’ discovery process for Zolgensma patent

Taljat David / Shutterstock.com

Two subsidiaries of French pharmaceutical giant Sanofi have accused rival Novartis of abusing the discovery process in a previous lawsuit, concerning royalties from a gene therapy treatment for spinal muscular atrophy.


Sanofi, Novartis, Genzyme, Aventis, gene editing, big pharma, patents

LSIPR